Hybrids Bearing in a Sentence

Manuscript Generator

Learn more from Hybrids Bearing

More Hybrids Bearing sentence examples

10.1016/j.bioorg.2019.103025

The novel hybrids bearing 4-aminopyridine (4-AP) tethered with substituted 1,3,4-oxadiazole nucleus were designed, synthesized, and evaluated for their potential AChE inhibitory property along with significant antioxidant potential.

Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions.

10.1002/ardp.201900086

From this perception, new quinoline hybrids bearing bioactive pharmacophores were synthesized.

Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids

10.1021/acs.joc.9b01501

A collection of chiral spirocyclic THN-oxindole hybrids bearing a quaternary carbon center at the β-position of THN have been developed.

Protecting Group-directed Diastereodivergent Synthesis of Chiral Tetrahydronaphthalene-fused Spirooxindoles via Bifunctional Tertiary Amine Catalysis.

Discover more insights into Hybrids Bearing

Keywords frequently search together with Hybrids Bearing

Narrow sentence examples with built-in keyword filters

10.1016/j.bmc.2019.02.031

Novel hybrids bearing a 2-aminopyrimidine (2-AP) moiety linked to substituted 1,3,4-oxadiazoles were designed, synthesized and biologically evaluated.

Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.

Learn more from Hybrids Bearing

An Overview of Hybrids Bearing

Hybrids Bearing
Encyclopedia

What is/are Hybrids Bearing?

Hybrids Bearing - The novel hybrids bearing 4-aminopyridine (4-AP) tethered with substituted 1,3,4-oxadiazole nucleus were designed, synthesized, and evaluated for their potential AChE inhibitory property along with significant antioxidant potential. [1] From this perception, new quinoline hybrids bearing bioactive pharmacophores were synthesized. [2] A collection of chiral spirocyclic THN-oxindole hybrids bearing a quaternary carbon center at the β-position of THN have been developed. [3] Novel hybrids bearing a 2-aminopyrimidine (2-AP) moiety linked to substituted 1,3,4-oxadiazoles were designed, synthesized and biologically evaluated. [4]

Novel Hybrids Bearing

The novel hybrids bearing 4-aminopyridine (4-AP) tethered with substituted 1,3,4-oxadiazole nucleus were designed, synthesized, and evaluated for their potential AChE inhibitory property along with significant antioxidant potential. [1] Novel hybrids bearing a 2-aminopyrimidine (2-AP) moiety linked to substituted 1,3,4-oxadiazoles were designed, synthesized and biologically evaluated. [2]